Clinical Trial Update: BeFluBu vs FluBuRux Conditioning in Haploidentical HCT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing BeFluBu vs FluBuRux conditioning regimens in haploidentical stem cell transplantation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoblastic Lymphoma
• Mixed Phenotype Acute Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• BUSULFAN (Busulfan)
• Bendamustine (Bendamustine)
• Fludarabine (Fludarabine)
• Rituximab (rituximab)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING